These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 22309134)
21. Catechin-mediated restructuring of a bacterial toxin inhibits activity. Chang EH; Huang J; Lin Z; Brown AC Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156 [TBL] [Abstract][Full Text] [Related]
22. Toxin-Triggered Liposomes for the Controlled Release of Antibiotics to Treat Infections Associated with Gram-Negative Bacteria. Li Z; Baidoun R; Brown AC bioRxiv; 2023 Sep; ():. PubMed ID: 37808632 [TBL] [Abstract][Full Text] [Related]
23. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli. Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499 [TBL] [Abstract][Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes. Kaur M; Kachlany SC Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107 [TBL] [Abstract][Full Text] [Related]
25. Receptor-Based Peptides for Inhibition of Leukotoxin Activity. Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342 [TBL] [Abstract][Full Text] [Related]
26. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin. Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475 [TBL] [Abstract][Full Text] [Related]
27. Surface charge markedly attenuates the nonlamellar phase-forming propensities of lipid bilayer membranes: calorimetric and (31)P-nuclear magnetic resonance studies of mixtures of cationic, anionic, and zwitterionic lipids. Lewis RN; McElhaney RN Biophys J; 2000 Sep; 79(3):1455-64. PubMed ID: 10969007 [TBL] [Abstract][Full Text] [Related]
28. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241 [TBL] [Abstract][Full Text] [Related]
29. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics. Krueger E; Brown AC Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022 [TBL] [Abstract][Full Text] [Related]
30. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303 [TBL] [Abstract][Full Text] [Related]
31. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. Lally ET; Golub EE; Kieba IR J Biol Chem; 1994 Dec; 269(49):31289-95. PubMed ID: 7983074 [TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane. Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197 [TBL] [Abstract][Full Text] [Related]
34. Cranberry Proanthocyanidins Neutralize the Effects of Ben Lagha A; Howell A; Grenier D Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483 [No Abstract] [Full Text] [Related]
35. Studies of the thermotropic phase behavior of phosphatidylcholines containing 2-alkyl substituted fatty acyl chains: a new class of phosphatidylcholines forming inverted nonlamellar phases. Lewis RN; McElhaney RN; Harper PE; Turner DC; Gruner SM Biophys J; 1994 Apr; 66(4):1088-103. PubMed ID: 8038381 [TBL] [Abstract][Full Text] [Related]
36. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans. Sampathkumar V; Velusamy SK; Godboley D; Fine DH Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341 [TBL] [Abstract][Full Text] [Related]
37. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730 [TBL] [Abstract][Full Text] [Related]
38. Evidence for the modulation of Pseudomonas aeruginosa exotoxin A-induced pore formation by membrane surface charge density. Rasper DM; Merrill AR Biochemistry; 1994 Nov; 33(44):12981-9. PubMed ID: 7947702 [TBL] [Abstract][Full Text] [Related]
39. Leukotoxin (LtxA/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes. Prince DJ; Patel D; Kachlany SC Sci Rep; 2021 Sep; 11(1):18086. PubMed ID: 34508147 [TBL] [Abstract][Full Text] [Related]
40. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans. Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]